WallStreetZenWallStreetZen

NASDAQ: CJJD
China Jo Jo Drugstores Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CJJD past revenue growth

How has CJJD's revenue growth performed historically?
Company
-9.48%
Industry
1.65%
Market
13.73%
CJJD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CJJD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CJJD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CJJD earnings and revenue history

Current Revenue
$148.8M
Current Earnings
-$21.1M
Current Profit Margin
-14.2%

CJJD Return on Equity

Current Company
-100.4%
Current Industry
-13.5%
Current Market
27.8%
CJJD's Return on Equity (-100.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CJJD announces earnings.

CJJD Return on Assets

Current Company
-21.4%
Current Industry
-3.6%
CJJD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CJJD Return on Capital Employed

Current Company
-84.62%
Current Industry
-7.4%
CJJD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CJJD vs Pharmaceutical Retailer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CJJD$148.81M-$19.96M-$21.14M+9.14%N/A
SSY$46.84M-$1.14M-$2.73M-1.55%N/A
BIMI$10.01M-$20.27M-$20.54M+5.61%N/A
MEDS$9.43M-$3.32M-$4.08M+24.00%N/A
MDVL$23.84M-$40.84M-$46.00M+120.05%N/A
View Top Pharmaceutical Retailer Stocks

CJJD earnings dates

Next earnings date
Nov 10, 2023

China Jo Jo Drugstores Holdings Earnings & Revenue FAQ

What were CJJD's earnings last quarter?

On Invalid Date, China Jo Jo Drugstores Holdings (NASDAQ: CJJD) reported Q1 2023 earnings per share (EPS) of N/A, up N/A year over year. Total China Jo Jo Drugstores Holdings earnings for the quarter were N/A. In the same quarter last year, China Jo Jo Drugstores Holdings's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy China Jo Jo Drugstores Holdings stock.

What was CJJD's earnings growth in the past year?

As of Q3 2023, China Jo Jo Drugstores Holdings's earnings has grown year over year. China Jo Jo Drugstores Holdings's earnings in the past year totalled -$21.14 million.

What is CJJD's earnings date?

China Jo Jo Drugstores Holdings's earnings date is Invalid Date. Add CJJD to your watchlist to be reminded of CJJD's next earnings announcement.

What was CJJD's revenue last quarter?

On Invalid Date, China Jo Jo Drugstores Holdings (NASDAQ: CJJD) reported Q1 2023 revenue of N/A up N/A year over year. In the same quarter last year, China Jo Jo Drugstores Holdings's revenue was N/A.

What was CJJD's revenue growth in the past year?

As of Q3 2023, China Jo Jo Drugstores Holdings's revenue has grown -9.48% year over year. This is 11.12 percentage points lower than the US Pharmaceutical Retailers industry revenue growth rate of 1.65%. China Jo Jo Drugstores Holdings's revenue in the past year totalled $148.81 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.